Leo Metro Cardiac Centre Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 31-07-2024
- Paid Up Capital ₹ 0.20 M
as on 31-07-2024
- Company Age 11 Year,
- Last Filing with ROC 31 Mar 2023
- Revenue 4.53%
(FY 2023)
- Profit -12.03%
(FY 2023)
- Ebitda -5.97%
(FY 2023)
- Net Worth 52.35%
(FY 2023)
- Total Assets 4.59%
(FY 2023)
About Leo Metro Cardiac Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Musthafa Mohammed, Muhamed Shaloob, Peedika Suma, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110KL2013PTC035737
- Company No.
035737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Wayanad, Kerala, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Leo Metro Cardiac Centre?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Muhamed Shaloob | Managing Director | 20-Dec-2013 | Current |
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Musthafa Mohammed | Nominee Director | 20-Dec-2013 | Current |
Peedika Suma | Director | 20-Dec-2013 | Current |
Thacholipaloli Surendran | Director | 20-Dec-2013 | Current |
Financial Performance and Corporate Structure Insights of Leo Metro Cardiac Centre.
Leo Metro Cardiac Centre Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.53% increase. The company also saw a substantial fall in profitability, with a 12.03% decrease in profit. The company's net worth Soared by an impressive increase of 52.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Leo Metro Cardiac Centre?
In 2023, Leo Metro Cardiac Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Metromed International Cardiac Centre Private LimitedActive 18 years 7 months
Musthafa Mohammed and Muhamed Shaloob are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Leo Metro Cardiac Centre?
Leo Metro Cardiac Centre has a workforce of 17 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leo Metro Cardiac Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leo Metro Cardiac Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.